BURLINGTON, ON, May 3, 2017 /CNW/ - EcoSynthetix Inc. (TSX:
ECO) ("EcoSynthetix" or the "Company"), a renewable chemicals company that produces a portfolio of commercially proven
bio-based products, today announced its financial and operational results for the three months ended March
31, 2017. Financial references are in U.S. dollars unless otherwise indicated.
Q1 2017 Highlights
- Advanced each of the ongoing late-stage trials for DuraBind with 10+ prospects in its wood composite pipeline
- Recorded net sales of $3.6 million in Q1 2017, up 22% compared to the same period in
2016
- Reduced adjusted EBITDA loss by 30% to $1.5 million in Q1 2017, compared to the same period
in 2016
- Maintained a strong balance sheet with cash and term deposits of $51.2 million as at
March 31, 2017
- Subsequent to the end of the quarter, won a new commercial account for EcoSphere® in a packaging application from Stora
Enso, a leading provider of renewable solutions in packaging, biomaterials, wood and paper
"Our No-Added-Formaldehyde product, DuraBind biopolymers, continues to attract a great deal of commercial interest from
manufacturers looking to reduce or eliminate the level of formaldehyde-based binders in their wood composite products," said
Jeff MacDonald, CEO of EcoSynthetix. "While we have made continuous and consistent shipments to
our first wood composite customer for more than seven months, we are also broadening our engagement at individual accounts where
industrial trials are being conducted on multiple lines. Our number one priority is to successfully close the prospects that are
well underway in the industrial trial process and continue building momentum in the market."
Financial Summary
Net Sales
Net sales were $3.6 million for the three months ended March 31,
2017 (Q1 2017), compared to $3.0 million for the same period in 2016. The 22% increase
was primarily due to higher sales volumes of $0.4 million, or 14%, and an increase in average
selling price which positively impacted sales by $0.2 million, or 8%. The increase in sales volumes
during the period was principally due to new commercial accounts. The increase in average selling price was primarily due to
favorable pricing dynamics.
Gross Profit
Gross profit was $0.8 million for Q1 2017, compared to $0.5
million in the same period in 2016. Gross profit as a percentage of sales was 22.2% for Q1 2017, compared to 16.1% in the
same period in 2016. Gross profit as a percentage of sales adjusted for manufacturing depreciation was 27.1% for Q1 2017,
compared to 22.8% for the same period in 2016. The improvement in gross profit was primarily due to higher average selling prices
and an increase in sales volume.
Selling, General and Administrative
(Excludes share-based compensation, depreciation, provision for termination benefits and foreign exchange gains and
losses)
Selling, general and administrative expenses (SG&A) were $1.2 million for Q1 2017, compared
to $1.6 million for the same period in 2016. The 23% decrease was primarily due to lower people
related costs and lower discretionary spending.
Research and Development
(Excludes share-based compensation, depreciation, provision for termination benefits and foreign exchange gains and
losses)
Research and development (R&D) costs were $1.3 million for Q1 2017, compared to $1.1 million for the same period in 2016. The increase was primarily due to lower government grants recognized
in the current quarter compared to the same period last year.
Foreign Exchange Gain
Foreign exchange gain was nominal for Q1 2017, compared to $0.2 million for the same period in
2016. The change was primarily due to the translation of cash balances denominated in Canadian dollars and exchange rate
fluctuations between the Canadian dollar versus U.S. dollar.
Adjusted EBITDA
Adjusted EBITDA loss was $1.5 million for Q1 2017, compared to a loss of $2.1 million for the same period in 2016. The 30% improvement was due to higher gross profit and lower
operating expenses in Q1 2017.
Net Loss
Net loss was $1.9 million, or $0.03 per common share, for Q1 2017
compared to a net loss of $2.4 million, or $0.04 per common share,
for the same period in 2016. The improvement was principally due to $0.3 million of higher gross
profit and $0.2 million of lower operating expenses, compared to the same period in 2016.
Liquidity
Cash on hand and term deposits were $51.2 million as at March 31,
2017, compared to $53.6 million as at December 31, 2016. Cash
on hand at March 31, 2017, excluding the term deposit, was $36.1
million.
Notice of Conference Call
EcoSynthetix will host a conference call on Thursday, May 4, 2017 at 8:30
AM ET to discuss its financial results. Jeff MacDonald, CEO, and Robert Haire, CFO, will co-chair the call. All interested parties can join the call by dialling (647) 427-7450
or (888) 231-8191. Please dial in 15 minutes prior to the call to secure a line. A live audio webcast of the conference call will
also be available at www.ecosynthetix.com. The
presentation will be accompanied by slides, which will be available via the webcast link and the Company's website. Please
connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required
to join the webcast.
1 Non-IFRS Financial Measures
This press release makes reference to certain non-IFRS measures. These non-IFRS measures are not recognized measures under
IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures
presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by
providing a further understanding of results of operations of EcoSynthetix from management's perspective. Accordingly, they
should not be considered in isolation nor as a substitute for analysis of the financial information of EcoSynthetix reported
under IFRS. The Company uses non-IFRS measures such as Adjusted EBITDA to provide investors with a supplemental measure of
operating performance and thus highlight trends in its core business that may not otherwise be apparent when relying solely on
IFRS financial measures. Management also believes that securities analysts, investors and other interested parties frequently use
non-IFRS measures in the evaluation of issuers. Management also uses non-IFRS measures in order to facilitate operating
performance comparisons from period to period, prepare annual operating budgets and assess the Company's ability to meet its
capital expenditure and working capital requirements.
Adjusted EBITDA is not a measure recognized under IFRS and does not have a standardized meaning prescribed by IFRS. See "IFRS
and Non-IFRS Measures." The Company presents Adjusted EBITDA because the Company believes it facilitates investors' use of
operating performance comparisons from period to period and company to company by backing out potential differences caused by
variations in capital structures (affecting relative interest expense), the book amortization of intangibles (affecting relative
amortization expense) and the age and book value of property and equipment (affecting relative depreciation expense). The Company
also presents Adjusted EBITDA because it believes it is frequently used by securities analysts, investors and other interested
parties as a measure of financial performance. Adjusted EBITDA as presented herein are not recognized measures under IFRS and
should not be considered as an alternative to operating income or net income as measures of operating results or an alternative
to cash flows as measures of liquidity. Adjusted EBITDA is defined as consolidated net income (loss) before net interest expense,
income taxes, depreciation, amortization, other non-cash expenses and charges deducted in determining consolidated net income
(loss).
The following table reconciles net loss to Adjusted EBITDA loss for the three months ended March 31,
2017 and March 31, 2016:
|
Three months ended
March 31, 2017
|
Three months ended
March 31, 2016
|
Net Loss
|
(1,903,638)
|
(2,369,222)
|
Depreciation
|
267,046
|
292,258
|
Share-based Compensation
|
314,021
|
142,000
|
Interest Income
|
(132,166)
|
(139,236)
|
Adjusted EBITDA Loss
|
(1,454,737)
|
(2,074,200)
|
About EcoSynthetix Inc. (www.ecosynthetix.com)
EcoSynthetix offers a range of sustainable engineered biopolymers that allow customers to reduce their use of harmful
materials, such as formaldehyde and styrene-based chemicals. The Company's flagship products, DuraBind™ and EcoSphere®, are used
to manufacture wood composites, paper and packaging, and enable performance improvements, economic benefits and sustainability.
The Company is publicly traded on the Toronto Stock Exchange (T:ECO).
Forward-Looking Statements
Certain statements in this Press Release constitute "forward-looking" statements that involve known and unknown risks,
uncertainties and other factors which may cause the actual results, performance, objectives or achievements of the Company, or
industry results, to be materially different from any future results, performance, objectives or achievements expressed or
implied by such forward looking statements. The forward-looking statements in this Press Release include, but are not limited to,
statements regarding the Company's expected product pipeline, plans to expand the Company's business into new markets, the
Company's ability to achieve organizational efficiencies, and other statements regarding the Company's plans and expectations in
2017. These statements reflect our current views regarding future events and operating performance and are based on information
currently available to us, and speak only as of the date of this Press Release. These forward-looking statements involve a number
of risks, uncertainties and assumptions and should not be read as guarantees of future performance or results, and will not
necessarily be accurate indications of whether or not such performance or results will be achieved. Those assumptions and risks
include, but are not limited to, the Company's ability to successfully allocate capital as needed and to develop new products, as
well as the fact that our results of operations and business outlook are subject to significant risk, volatility and uncertainty.
Many factors could cause our actual results, performance or achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by such forward-looking statements, including the factors identified
in the "Risk Factors" section of the Company's Annual Information Form dated March 30, 2017. Should
one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove
incorrect, actual results may vary materially from those described in this Press Release as intended, planned, anticipated,
believed, estimated or expected. Unless required by applicable securities law, we do not intend and do not assume any obligation
to update these forward-looking statements.
EcoSynthetix Inc.
|
|
|
Interim Consolidated Balance Sheets
|
|
|
(Unaudited)
|
|
|
|
|
|
(expressed in US dollars)
|
|
|
|
|
|
|
March 31,
2017
|
December 31,
2016
|
Assets
|
|
|
|
|
|
Current assets
|
|
|
Cash
|
36,057,340
|
38,517,278
|
Term deposit
|
15,107,828
|
-
|
Accounts receivable
|
1,848,360
|
2,199,289
|
Inventory
|
3,329,615
|
3,216,016
|
Government grants receivable
|
162,377
|
168,562
|
Prepaid expenses
|
142,321
|
165,352
|
|
56,647,841
|
44,266,497
|
|
|
|
Non-current assets
|
|
|
Term deposit
|
-
|
15,043,557
|
Property, plant and equipment
|
7,826,353
|
7,933,584
|
Total assets
|
64,474,194
|
67,243,638
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
Current liabilities
|
|
|
Trade payables and accrued liabilities
|
2,152,077
|
3,070,203
|
Accrued termination benefits
|
118,055
|
415,888
|
Total liabilities
|
2,270,132
|
3,486,091
|
|
|
|
Shareholders' Equity
|
|
|
Common shares
|
493,613,481
|
493,359,612
|
Contributed surplus
|
8,836,291
|
8,740,007
|
Accumulated deficit
|
(440,245,710)
|
(438,342,072)
|
Total shareholders' equity
|
62,204,062
|
63,757,547
|
|
|
|
Total liabilities and shareholders' equity
|
64,474,194
|
67,243,638
|
EcoSynthetix Inc.
|
|
|
Interim Consolidated Statements of Operations and Comprehensive
Loss
|
|
|
For the three months ended March 31, 2017 and March 31, 2016
|
|
|
(Unaudited)
|
|
|
|
|
|
(expressed in US dollars)
|
|
|
|
|
|
|
2017
|
2016
|
|
|
|
Net sales
|
3,602,129
|
2,964,470
|
|
|
|
Cost of sales
|
2,802,169
|
2,486,147
|
|
|
|
Gross profit on sales
|
799,960
|
478,323
|
|
|
|
Expenses
|
|
|
Selling, general and administrative
|
1,489,666
|
1,562,241
|
Research and development
|
1,346,098
|
1,224,851
|
Provision for termination benefits
|
-
|
199,689
|
|
|
|
|
2,835,764
|
2,986,781
|
|
|
|
Loss from operations
|
(2,035,804)
|
(2,508,458)
|
|
|
|
Interest income
|
132,166
|
139,236
|
|
|
|
Net loss and comprehensive loss
|
(1,903,638)
|
(2,369,222)
|
|
|
|
Basic and diluted loss per common share
|
(0.03)
|
(0.04)
|
|
|
|
Weighted average number of common shares outstanding
|
59,515,232
|
59,275,758
|
EcoSynthetix Inc.
|
|
|
Interim Consolidated Statements of Cash Flows
|
|
|
For the three months ended March 31, 2017 and March 31, 2016
|
|
|
(Unaudited)
|
|
|
|
|
|
(expressed in US dollars)
|
|
|
2017
|
2016
|
Cash provided by (used in)
|
|
|
|
|
|
Operating activities
|
|
|
Net loss and comprehensive loss
|
(1,903,638)
|
(2,369,222)
|
Items not affecting cash
|
|
|
|
Depreciation
|
267,046
|
292,258
|
|
Share-based compensation
|
314,021
|
142,000
|
|
Unrealized foreign exchange gain
|
(8,839)
|
(161,686)
|
|
Other
|
(108,237)
|
(111,151)
|
Changes in non-cash working capital
|
|
|
|
Accounts receivable
|
378,352
|
(322,833)
|
|
Inventory
|
(102,291)
|
368,255
|
|
Government grants receivable
|
(59,521)
|
(133,505)
|
|
Prepaid expenses
|
23,031
|
(57,576)
|
|
Trade payables and accrued liabilities
|
(918,126)
|
484,382
|
|
Accrued termination benefits
|
(297,833)
|
108,215
|
|
(2,416,035)
|
(1,760,863)
|
|
|
|
Investing activities
|
|
|
Purchase of property, plant and equipment
|
(171,123)
|
(277,156)
|
Purchase of term deposit
|
-
|
(15,000,000)
|
|
(171,123)
|
(15,277,156)
|
|
|
|
Financing activity
|
|
|
Exercise of common share options
|
8,709
|
-
|
Proceeds from government grants
|
65,706
|
295,831
|
|
74,415
|
295,831
|
|
|
|
|
|
|
Effect of exchange rate changes on cash
|
52,805
|
213,733
|
|
|
|
Decrease in cash during the period
|
(2,459,938)
|
(16,528,455)
|
|
|
|
Cash - Beginning of period
|
38,517,278
|
60,717,658
|
|
|
|
Cash - End of period
|
36,057,340
|
44,189,203
|
SOURCE EcoSynthetix Inc.
View original content: http://www.newswire.ca/en/releases/archive/May2017/03/c5373.html